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Abstract
Background: PDZK1 is a four PDZ-domain containing protein that binds to the carboxy terminus of the HDL receptor,
scavenger receptor class B type I (SR-BI), and regulates its expression, localization and function in a tissue-specific manner.
PDZK1 knockout (KO) mice are characterized by a marked reduction of SR-BI protein expression (,95%) in the liver (lesser or
no reduction in other organs) with a concomitant 1.7 fold increase in plasma cholesterol. PDZK1 has been shown to be
atheroprotective using the high fat/high cholesterol (‘Western’) diet-fed murine apolipoprotein E (apoE) KO model of
atherosclerosis, presumably because of its role in promoting reverse cholesterol transport via SR-BI.
Principal Findings: Here, we have examined the effects of PDZK1 deficiency in apoE KO mice fed with the atherogenic
‘Paigen’ diet for three months. Relative to apoE KO, PDZK1/apoE double KO (dKO) mice showed increased plasma lipids
(33% increase in total cholesterol; 49 % increase in unesterified cholesterol; and 36% increase in phospholipids) and a 26%
increase in aortic root lesions. Compared to apoE KO, dKO mice exhibited substantial occlusive coronary artery disease:
375% increase in severe occlusions. Myocardial infarctions, not observed in apoE KO mice (although occasional minimal
fibrosis was noted), were seen in 7 of 8 dKO mice, resulting in 12 times greater area of fibrosis in dKO cardiac muscle.
Conclusions: These results show that Paigen-diet fed PDZK1/apoE dKO mice represent a new animal model useful for
studying coronary heart disease and suggest that PDZK1 may represent a valuable target for therapeutic intervention.
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Introduction
Hypercholesterolemia is recognized as one of the most
important predisposing risk factors for the development of
occlusive coronary arterial atherosclerosis and myocardial infarc-
tion [1]. Under typical experimental conditions, neither LDL
receptor nor apoE KO mice exhibit robust occlusive coronary
artery disease associated with myocardial infarction, heart
dysfunction and death during the first six months of life (see for
example [2]). After 8 months (chow diet) [3] or 5 months (Western
diet) [4] of age, apoE KO mice develop atherosclerotic lesions in
the proximal segments of coronary arteries, resulting presumably
from the extension of lesions present in the aortic root [4].
Occasional myocardial fibrosis has been observed in 10 month old
apoE KO mice [4]. In contrast, there is robust aortic root and
aortic atherosclerosis in these mice, and they are commonly used
as a model of human atherosclerosis [5,6,7].
High density lipoprotein (HDL)a n di t sr e c e p t o r ,s c a v e n g e r
receptor class B type I (SR-BI), have been described as
atheroprotective [8,9,10,11,12]. They participate in the trans-
port of cholesterol from peripheral tissues (e.g. atheromatous
plaques) to the liver and subsequent excretion into the bile, a
process called reverse cholesterol transport [13,14,15]. SR-BI is a
509 amino acid membrane-associated protein predominantly
expressed in the liver and steroidogenic organs, and also in
enterocytes in the small intestine, macrophages and endothelial
cells [15,16,17,18,19,20,21].
Several experimental models have shown that overexpression of
SR-BI in murine liver decreases the extent of atherosclerosis, even
though it decreases HDL-plasma cholesterol concentration
[22,23,24,25]. Partial or total loss of SR-BI increases atheroscle-
rosis in several murine models [12,26,27,28].
Mice deficient in both SR-BI and apolipoprotein E (SR-BI/
apoE double knockout (dKO) mice) fed a normal chow diet not
only exhibit dramatically enhanced hypercholesterolemia and
accelerated aortic root atherosclerosis [12], but also exhibit rapid
onset occlusive coronary artery atherosclerosis, myocardial
infarction and premature death (mean age of death ,6 weeks of
age) [11]. Thus, SR-BI/apoE dKO mice provide a very rapid,
small animal model that mimics many cardinal features of human
coronary heart disease [2,11,29].
PDZK1 is a four PDZ domain protein that binds to and
regulates the expression of SR-BI in a tissue specific manner
[30,31,32,33]. Loss of PDZK1 in PDZK1 KO mice is accompa-
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concomitant ,1.7 fold increase in plasma total cholesterol levels.
However, loss of PDZK1 does not affect SR-BI expression in
steroidogenic tissues [32] or macrophages [21]. These findings led
to the conclusion that PDZK1 is a tissue specific adaptor protein
for SR-BI, and joins ARH (autosomal recessive hypercholesterol-
emia gene) in a new class of tissue specific adaptor proteins for
lipoprotein receptors. ARH is an adaptor for the LDL receptor
[34] that regulates this receptor in a tissue specific fashion.
We have previously shown that PDZK1 is atheroprotective
in mice [21]. PDZK1/apoE dKO mice fed with a high fat/
high cholesterol diet (Western diet) develop increased aortic
root atherosclerosis compared to apoE single KO mice, but
fail to develop occlusive coronary artery disease and myocardial
infarction [21].
In this report, we examined the effects of 3 months of feeding
another atherogenic diet, the high fat, high cholesterol, cholate
containing ‘Paigen’ diet on PDZK1/apoE dKO mice and control
apoE single KO mice. We found that the Paigen diet induced a
more severe hypercholesterolemia and greater aortic atheroscle-
rosis in PDZK1/apoE dKO mice than in the apoE KO controls.
Strikingly, in contrast to the Western diet, the Paigen diet induced
development of occlusive coronary arterial atherosclerosis and
myocardial infarction in PDZK1/apoE dKO mice not seen in
apoE KO controls. Thus, the Paigen diet-fed PDZK1/apoE dKO
mice represent a new murine model of coronary heart disease
and suggest that PDZK1 may represent a valuable target for
therapeutic intervention.
Materials and Methods
Animal protocols were reviewed and approved by the
respective Animal Care & Use Committees at the Beth Israel
Deaconess Medical Center and the Massachusetts Institute of
Technology.
Animals
ApoE deficient mice (C57BL/6 background) were purchased
from Jackson Laboratories (Bar Harbor, ME), mated with
PDZK1 deficient mice (129 SvEv background), and backcrossed
for 6 generations into C57BL/6 background to generate the
PDZK1/apoE double knockout (dKO) and apoE single KO
mice as previously described [21]. As a result, experiments were
conducted using apoE single KO and PDZK1/apoE dKO male
mice with ,98.5% C57BL/6/1.5% 129 SvEv background.
Genotypes were determined by PCR using established protocols
([35] and Jackson Laboratories web site). For analyses of
lipoproteins (n=8–25 as shown in Table 1) and atherosclerosis
(n=8 per group) and cardiac morphology (n=8 per group),
approximately 4-week-old animals were fed a ‘‘Paigen diet’’
from Harlan Teklad (Madison, WI) containing 7.5% cocoa
butter, 15.8% fat, 1.25% cholesterol, 0.5% sodium cholate for 3
months [36].
Morphologic and Biochemical Analyses
Mice were anesthetized. Blood was obtained by cardiac
puncture using heparinized syringes and centrifuged to obtain
plasma. Hearts were excised after a short in vivo perfusion with
PBS, weighted and frozen in OCT compound. Transverse frozen
sections (10 mm) were stained with Oil Red O/hematoxylin and
atherosclerotic lesions were measured by planimetry as the sum of
the cross-sectional areas using image measure/SPOT software
(Diagnostics Instruments, Sterling Heights, MI) in the aortic root
as previously described [12]. Coronary arteries were visually
scored according to the severity of their occlusion status as follows:
severely occluded (50–100%), partially occluded (10–50%) and
minor occlusions (0–10%) [37,38]. Cardiac fibrosis was evaluated
on cryosections stained with Mason’s Trichrome (Sigma, St Louis,
MO). Digital images of sections collected using a Nikon E600
microscope with a SPOT digital camera and software (Diagnostic
Instruments, Inc.) were analyzed using OpenLab software
(Improvision, MA) and color-based thresholding segmentation of
the images (32 bits/pixel, RGB). To calculate the percentage of
cardiac fibrosis, we defined total ventricular myocardial tissue area
as the total number of all blue and red pixels in the image,
excluding atrial tissue and all valve leaflets. Fibrotic area was then
defined as the total number of blue pixels. % cardiac fibrosis =
(fibrotic area/total tissue area) 6100 [37,39].
Immunoblots were performed as previously described [40].
Briefly, total liver samples (40–50 mg of protein/sample) were size-
fractionated by 10% SDS-PAGE and immunoblotted on nitro-
cellulose membranes with either polyclonal antipeptide antibodies
for SR-BI [16] or for actin (used as protein loading control,
Sigma). Antibody binding to protein samples was visualized by
enhanced chemiluminescence using Super Signal West Pico
Luminal reagents (Pierce, Rockford, IL). In order to determine if
the Paigen diet induced changes in the expression of hepatic SR-
BI, the relative amounts of SR-BI were measured using a Kodak
Image Station 440 CF and Kodak 1D software in liver samples
from apoE KO and PDZK1/apoE dKO mice fed chow or Paigen
diet for three months (three mice per group). The results were
normalized with respect to the level of actin expression in the
respective tissue samples.
Immunoperoxidase studies to determine the respective contri-
bution of macrophages and smooth muscle cells in aortic root
atherosclerotic lesions were performed using CD68 (Serotec) and
alpha smooth muscle actin antibodies (Thermo Scientific)
according to manufacturer’s recommendation. Five-mm fixed-
frozen sections were stained with the anti-CD68 or anti-smooth
muscle actin antibodies, followed by biotinylated either anti-rat or
anti-mouse IgG, visualized by immunoperoxidase staining, and
counterstained with Harris modified hematoxylin, as described
previously [32].
Total and unesterified cholesterol, phospholipids and triglycer-
ides were measured using kits (Wako Chemical, Richmond, VA).
FPLC size fractionation of plasma lipoproteins was performed as
previously described [41].
Table 1. Plasma lipid levels and body weights of apoE KO
and PDZK1/apoE dKO mice.
Genotype TC UC UC:TC PL TG Wt
apoE KO 1898662
a 517614
b 0.2760.004
c 553623
d 67682 5 60.6
e
PDZK1/apoE
dKO
2529682 770633 0.3160.01 751622 85692 8 60.5
Four month old animals were fasted for 4 hours prior to sample collection.
Values are represented as mean6standard error from 8–25 animals (mean 20
animals) per group. Statistical significance was determined by pairwise
comparisons of each value from PDZK1/apoE dKO mice with apoE KO controls
by using unpaired Student’s t test. The abbreviations and units used are TC
(total plasma cholesterol, mg/dL), UC (plasma unesterified cholesterol, mg/dL),
UC:TC (plasma unesterified cholesterol to total plasma cholesterol ratio), PL
(plasma phospholipids, mg/dL), TG (plasma triglycerides, mg/dL) and Wt (body
weights, g).
a, b, c, eP,0.01
dP,0.05
doi:10.1371/journal.pone.0008103.t001
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A value of P,0.05 between experimental groups was consid-
ered to represent a significant difference using a 2-tailed, unpaired
Student’s t test or one-way ANOVA with Tukey’s multiple
comparisons post-test where appropriate. Reported values repre-
sent mean 6 standard error of the mean.
Results
We have previously shown that PDZK1 confers protection
against aortic root atherosclerosis in apoE KO mice fed an
atherogenic, Western-type, high fat/high cholesterol diet for 3
months [21]. Under these conditions, there was no evident
occlusive coronary arterial atherosclerosis nor cardiac damage. To
explore further the consequences of PDZK1 deficiency in apoE
KO mice on atherosclerosis and the heart, we subjected mice to a
more severe, cholate-containing atherogenic diet (Paigen diet).
Four week-old apoE single and PDZK1/apoE dKO mice were fed
a Paigen diet (7.5% cocoa butter, 15.8% fat, 1.25% cholesterol,
0.5% sodium cholate) for three months. At this stage, plasma was
obtained and mice were weighed and sacrificed to analyze the
extent of aortic root atherosclerosis and cardiac damage.
We previously showed that loss of PDZK1 causes a dramatic
reduction in hepatic SR-BI expression in otherwise wild-type mice
[32] or in apoE KO mice fed either a standard lab chow or a
Western-type diet [21]. However, the effect of PDZK1 ablation on
SR-BI levels in the liver of Paigen diet-fed animals was not known.
Western blot analyses of Paigen diet-fed animals (Fig. 1) showed a
dramatic decrease in the levels of SR-BI protein expression in the
livers of PDZK1/apoE dKO animals when compared to apoE
KO animals. Quantification experiments showed that the Paigen
diet did not change the expression of SR-BI in both apoE KO
mice (Relative fold change in SR-BI liver expression in apoE KO
mice fed Paigen diet versus chow diet =1.2060.18, p=0.34) and
PDZK1/apoE dKO mice (Relative fold change in SR-BI liver
expression in PDZK1/apoE dKO fed Paigen diet versus chow
diet =1.1760.60, p=0.79).
The dramatic reduction in hepatic SR-BI by ablation of the
PDZK1 gene in Paigen diet-fed apoE KO mice was accompanied
by increased plasma levels of total cholesterol (33%), unesterified
cholesterol (49%), and phospholipids (36%) as well as an increase
in the unesterified to total cholesterol ratio (14%) and total body
weight (13%) (Table 1).
Figure 2 shows the size distribution profiles of cholesterol in
plasma lipoproteins measured by FPLC. As previously reported
[3,5,6], most of the plasma cholesterol in apoE KO mice is carried
in VLDL-size particles. The plasma lipoprotein profile of
PDZK1/apoE dKO mice was similar, but the VLDL-size peak
was higher (Fig. 2). Under the conditions used for these
experiments (substantial dilution of the samples because of the
high total cholesterol levels), we did not detect HDL-size peaks in
any of the samples from PDZK1/apoE dKO mice, whereas we
occasionally observed a small HDL peak in apoE KO samples.
The unesterified to total cholesterol (UC:TC) ratio of FPLC
fractions from the VLDL region (not shown) indicated that the
UC:TC ratio was higher in PDZK1/apoE dKO mice, consistent
with the findings from total plasma measurements.
Hyperlipidemia is a risk factor for atherosclerosis and
coronary heart disease [1]. Because of the increased plasma
lipids in Paigen diet fed PDZK1/apoE dKO compared to apoE
KO mice, we next evaluated atherosclerosis in the aortic roots
and coronary arteries of these mice. Representative images of
frozen sections of aortic roots, in which neutral lipids were
stained with Oil Red O (top panels A and B), and quantification
of this staining as a measure of atherosclerosis (right top panel)
are shown in Figure 3. Both PDZK1/apoE dKO and apoE KO
mice showed significant amounts of atherosclerosis. There was a
26% increase in the average lesion area in the aortic roots of
PDZK1/apoE dKO mice compared to those of apoE KO mice
(0.825 mm
260.057 versus 0.654 mm
260.024, 8 animals per
group, P=0.015). These results confirm our previous studies
showing that PDZK1 is atheroprotective in the apoE KO mouse
[21]. Immunohistochemical staining of the sections with
antibodies that recognize macrophages (CD68) and smooth
muscle cells (alpha-smooth muscle actin) showed that macro-
phages were overwhelmingly the most abundant cellular
component of the atherosclerotic lesions in both apoE KO and
PDZK1/apoE dKO mice, while smooth muscle cells were less
abundant (Figure 3, C–F).
A common feature of human heart disease isocclusive coronary
arterial atherosclerotic lesions and associated myocardial fibrosis.
Figure 1. Immunoblot analysis of hepatic SR-BI expression.
Mice with the indicated genotypes were fed a high fat/high cholesterol/
cholate-containing ‘‘Paigen’’ diet for three months. Livers were
harvested and subjected to immunoblotting using anti-SR-BI and
anti-actin (loading control) antibodies as described in Materials and
Methods.
doi:10.1371/journal.pone.0008103.g001
Figure 2. Lipoprotein cholesterol profiles from apoE KO and
PDZK1/apoE dKO mice. Plasma harvested from individual mice fed a
Paigen diet for three months was size fractionated using FPLC, and the
total cholesterol contents of the fractions (mg/dL plasma) were
determined by enzymatic assay. Profiles averaged from 2 independent
experiments for each genotype, each composed of pooled plasma from
six apoE KO (open circles) and six PDZK1/apoE dKO (filled circles) mice
per experiment are shown. Approximate elution positions of human
VLDL, IDL/LDL and HDL are indicated.
doi:10.1371/journal.pone.0008103.g002
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recapitulate these phenomena, especially after relatively short
times (,6 months) of disease development [2,11,29,42]. Notable
examples include the SR-BI/apoE dKO mice on chow diet [11]
and SR-BI/HypoE on a Paigen diet [42]. We previously did not
observe substantial coronary arterial occlusion nor myocardial
fibrosis in PDZK1/apoE dKO mice fed a Western diet for three
months [21]. We therefore explored the effects of the Paigen-diet
on these features of cardiac pathology. The extent of coronary
arterial occlusions in apoE single KO and PDZK1/apoE dKO
mice (Fig. 4, A–C) was assessed quantitatively by classifying the
coronary arteries observed in frozen, stained cross sections into
three categories depending on the severity of occlusions as follows:
severely occluded (50–100% of the lumen occluded), partially
occluded (10–50%) and minor occlusions (0–10%), as described
previously [37,38]. Occlusions were found in the mid- to distal
portions of the coronary arteries. Oil Red O staining showed that
these arteries were occluded almost exclusively by lipid-rich
lesions, with very few cells present in the lesions (Fig. 4B). In
addition, no thrombi were observed. Trichrome stained (Fig. 4C)
images of occluded coronary arteries taken from the infarcted
areas showed perivascular fibrosis, confirming that the infarcts
were the direct consequence of the occluded coronary arteries.
Figure 4 (right top panel) shows that in PDZK1/apoE dKO
relative to apoE KO mice there was a 375% increase in the
percentage of severely occluded (P,0.001) and with a concom-
itant 47% decrease in vessels with little or no occlusions
(P,0.001).
Occluded coronary arteries are commonly implicated in
myocardial infarctions in humans. To determine if the relatively
high abundance of severely occluded arteries in PDZK1/apoE
dKO mice were associated with higher incidence of myocardial
infarction, we stained cardiac sections of both PDZK1/apoE
dKO and apoE single KO mice with Masson trichrome to identify
areas of myocardial infarction and fibrosis (blue stain, Fig. 4, D–
E). ApoE single KO mice hearts showed no myocardial infarction
and only occasional, minimal amounts of fibrosis, while
myocardial infarctions were observed in 7 out of 8 (88%)
PDZK1/apoE dKO mice. Quantitative evaluation of fibrosis
indicated that there was ,12 times more fibrosis in cardiac
muscle of PDZK1/apoE dKO mice than in apoE KO mice
(6.39%62.2 vs 0. 52%60.2, P=0.02) (Fig. 4, right bottom panel).
We did not observe evidence of gross cardiac dysfunction
(cardiomagaly or pulmonary edema) in either experimental
group. Indeed, no significant difference in cardiac size between
apoE KO and PDZK1/apoE dKO mice was observed (e.g., heart
weight to body weight ratios were 3.7560.10 mg/g in apoE KO
(n=6) and 4.1160.25 mg/g in PDZK1/apoE dKO (n=8) mice,
P=0.27). A small percentage of mice died during the course ofthe
study, however the death rate was not statistically different
between the two genotypes (apoE KO: 4%, PDZK1/apoE dKO:
6.6%). The majority of deaths happened early in the course of the
study (less that a month of feeding).
These results suggest that the PDZK1/apoE dKO mice
subjected to Paigen diet represent a new animal model to study
atherosclerotic coronary heart disease.
Figure 3. Aortic root atherosclerosis in Paigen diet-fed apoE KO and PDZK1/apoE dKO mice. Hearts were harvested from Paigen diet-fed
apoE KO (A, C–D) and PDZK1/apoE dKO (B, E–F) mice as described in Methods (n=8 per genotype). Left top panels: A–B: representative cross-sections
of Oil red O-stained aortic root lesions. (magnification, 620). Right top panel: quantification of aortic root atherosclerosis by planimetry. Unpaired
Student’s t-test was used to determine statistical significance. Bottom panels: immunohistochemistry of aortic root atherosclerotic plaques using
CD68 (C and E) or alpha-smooth muscle actin a-SMA) (D and F) antibodies show that macrophages compose the overwhelming cell population of
aortic root atherosclerotic plaques and that smooth muscle cells are rare in both apoE KO (C–D) and PDZK1/apoE dKO (E–F) mice. ‘‘L’’ indicates the
vascular lumen, arrows indicate representative positive cells (magnification, 6100).
doi:10.1371/journal.pone.0008103.g003
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In this study, we describe a new murine model of diet-induced
coronary heart disease, the Paigen-diet-fed PDZK1/apoE dKO
mouse. ApoE KO and PDZK1/apoE dKO mice were fed a high
fat/high cholesterol diet supplemented with cholate (Paigen diet
[36]) for three months to study the consequences of PDZK1 gene
inactivation on lipoprotein metabolism, atherosclerosis and
coronary heart disease. Previously, we had shown that PDZK1
deficiency enhances aortic root atherosclerosis in apoE deficient
mice on a Western-type high fat/high cholesterol diet, but did not
markedly induce occlusive coronary arterial atherosclerosis or
myocardial infarction [21]. Consistent with our previous results,
we found that PDZK1 is atheroprotective for apoE mice fed the
more severe Paigen diet. PDZK1/apoE dKO mice exhibited a
26% increase in the areas of aortic root lesions compared to apoE
KO mice. However, unlike the case with Western diet feeding
[21], we found that Paigen diet-fed PDZK1/apoE dKO, but not
apoE single KO, mice were characterized by substantial occlusive
coronary artery disease and the presence of myocardial infarctions.
The dramatic loss of hepatic SR-BI protein in the livers of
Paigen diet-fed PDZK1/apoE KO mice clearly contributed to
their dyslipidemia and possibly played a role to the relatively
unusual murine early onset occlusive coronary artery disease. In
addition, it is possible that the loss of PDZK1 in apoE KO mice
might influence atherosclerosis and coronary heart disease via, as
yet not identified, SR-BI-independent pathways.
Loss of PDZK1 in apoE KO mice resulted in elevated plasma
unesterified cholesterol, UC:TC ratio and phospholipids on both
Western diet- and Paigen diet-fed mice ([21], this study), but only
in the Paigen diet-fed PDZK1/apoE dKO mice did we observe
statistically significant elevations in total plasma cholesterol and
phospholipids. The influence of these differences in plasma
lipoproteins on the differences in occlusive coronary arterial
disease in these mice remains to be determined. We previously
showed that the inactivation of PDZK1 did not affect SR-BI
levels in two cell types known to be implicated in development
of atherosclerosis, macrophages and endothelial cells [21]. In
addition, loss of PDZK1 did not affect the uptake of lipid from
HDL in macrophages [21]. However, Shaul et al. have reported
that SR-BI dependent regulation of endothelial cell function (e.g.,
control of eNOS activity by extracellular HDL) is disrupted in the
absence of PDZK1 [43]. Thus, a disruption of SR-BI dependent
endothelial cell function might have contributed to the diet-
induced occlusive coronary artery disease.
Hyperlipidemia is a well known risk factor for coronary heart
disease [1]. Complete loss of SR-BI in normal chow-fed apoE KO
mice causes severe hypercholesterolemia associated with coronary
Figure 4. Effects of loss of PDZK1 on coronary atherosclerosis and cardiac fibrosis in apoE KO mice. Hearts were harvested from Paigen
diet-fed mice as described in Methods (n=8 per genotype). Left panels: A–B: representative cross-sections of Oil red O-stained (A–B) or trichrome-
stained (C) myocardial coronary arterioles, showing unremarkable arterioles in apoE KO (A) and totally occluded arterioles in PDZK1/apoE dKO (B–C)
mice (magnification, 6100). The Oil red O stain shows that the coronary arteriole is occluded almost exclusively by lipid-rich lesions (B), while the
trichrome stain shows that the arteriole is surrounded by fibrosis in an area of myocardial infarction in a PDZK1/apoE dKO mouse (C). D–E: trichrome
stained sections of hearts showing areas of infarction/fibrosis stained blue in PDZK1/apoE dKO (E), while they are absent in apoE KO (D) mice
(magnification, 610). Right top panel: quantification of coronary artery occlusions in apoE KO and PDZK1/apoE dKO mice. Statistically significant
differences by ANOVA Tukey posthoc test comparing the two genotypes within a given group are indicated as: P,0.001. Right bottom panel:
quantification of cardiac fibrosis in apoE KO and PDZK1/apoE dKO mice. Unpaired Student’s t-test was used to determine statistical significance.
doi:10.1371/journal.pone.0008103.g004
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[11], whereas PDZK1/apoE dKO mice fed either chow or
Western high fat diets do not exhibit cardiac fibrosis, myocardial
infarction nor premature cardiac death [21]. In the present study,
we show that feeding PDZK1/apoE dKO mice with the more
severe Paigen diet resulted in the formation of coronary occlusions
and cardiac fibrosis, but this was not associated with symptoms
of cardiac dysfunction (e.g., cardiomegaly) during the 3 month
duration of this study. The reason(s) for the less severe
pathophysiology in PDZK1/apoE dKO compared to SR-BI/
apoE dKO mice remain to be established. It might be attributed to
the atheroprotective effect of residual SR-BI expression that
persists following inactivation of the PDZK1 gene (5% in the liver,
50% in the small intestine and unchanged in steroidogenic organs,
endothelial cells and macrophages) [21,32]. In addition, the level
of hepatic expression of a minor SR-BI isoform, SR-BII [44], is
unaffected by the loss of PDZK1 [32]. One distinctive difference in
lipoprotein metabolism between chow-fed PDZK1/apoE and SR-
BI/apoE dKO mice that is likely to reflect differences in the tissue
specificity and/or absolute levels of SR-BI/II expression and
function is the large difference in the UC:TC ratios in their plasma
lipoproteins: ,0.8 in SR-BI/apoE dKO [45] and ,0.4 in
PDZK1/apoE dKO [21] mice (,0.25 in wild-type mice).
However, the relatively low absolute values and small relative
differences for the plasma UC:TC ratios in Paigen diet-fed apoE
KO (0.27) and PDZK1/apoE dKO (0.31) mice caste doubt on
the importance of this characteristic of plasma lipoproteins in
influencing coronary arterial atherogenesis and myocardial
infarction in this system.
The PDZK1/apoE dKO mouse model joins a growing list of
animal models that share features of classic human coronary heart
disease [11,29,42,46] and may thus prove useful for characterizing
mechanisms underlying disease development and testing ap-
proaches for prevention and treatment. Our findings also suggest
that PDZK1 itself might be an attractive target for pharmacologic
intervention for targeted therapies.
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